Chinese radiopharma firm C Ray raises over $100m Series A+

Chinese radiopharma firm C Ray raises over $100m Series A+

Photo from C Ray Therapeutics' website

17 November, 2024

Edited by: Deepshikha Monga

C Ray Therapeutics GL Ventures Shenzhen Capital Group Tailong Capital

Printed by Unregistered user on Mon, 08 Dec 2025 01:00:16 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Goldman-backed biotech company Septerna raises $288m in US IPO

Earnings and Results

SG biotech firm Lion TCR's losses up 27% in 2023, no revenue yet

Read more from Greater China

Policy & Regulations

China proposes sweeping new rules to tighten listed company oversight

Alibaba to retire Ele.me brand amid instant-retail push